Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TORRACTO trial of tiotropium + olodaterol on exercise endurance in COPD
2011-004253-11Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tiotropium and olodaterol in chronic obstructive pulmonary disease (COPD) (3 arms), sponsored by Boehringer Ingelheim. Started Dec 2011; status: completed.
02
Drugs
tiotropiumolodaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2011-004253-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004253-11.